These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1358622)

  • 21. Drug-related blood dyscrasias in a Swedish reporting system, 1985-1994.
    Wiholm BE; Emanuelsson S
    Eur J Haematol Suppl; 1996; 60():42-6. PubMed ID: 8987240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, etiology and bone marrow characteristics of non-chemotherapy-induced agranulocytosis.
    Apinantriyo B; Lekhakula A; Rujirojindakul P
    Hematology; 2011 Jan; 16(1):50-3. PubMed ID: 21269568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-associated agranulocytosis: 20 years of reporting in The Netherlands (1974-1994).
    van der Klauw MM; Wilson JH; Stricker BH
    Am J Hematol; 1998 Mar; 57(3):206-11. PubMed ID: 9495370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfasalazine-induced DRESS and severe agranulocytosis successfully treated by granulocyte colony-stimulating factor.
    Fathallah N; Slim R; Rached S; Hachfi W; Letaief A; Ben Salem C
    Int J Clin Pharm; 2015 Aug; 37(4):563-5. PubMed ID: 25854308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus.
    Wadelius M; Eriksson N; Kreutz R; Bondon-Guitton E; Ibañez L; Carvajal A; Lucena MI; Sancho Ponce E; Molokhia M; Martin J; Axelsson T; Kohnke H; Yue QY; Magnusson PKE; Bengtsson M; Hallberg P;
    Clin Pharmacol Ther; 2018 May; 103(5):843-853. PubMed ID: 28762467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholestasis and fatal agranulocytosis complicating sulfasalazine therapy: case report and review of the literature.
    Mitrane MP; Singh A; Seibold JR
    J Rheumatol; 1986 Oct; 13(5):969-72. PubMed ID: 2880997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agranulocytosis: incidence and risk factors.
    Alvir JM; Lieberman JA
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():137-8. PubMed ID: 7961558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leucopenia in adult Still's disease during treatment with azathioprine and sulphasalazine.
    Bliddal H; Helin P
    Clin Rheumatol; 1987 Jun; 6(2):244-50. PubMed ID: 2887331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperleucocytosis following G-CSF treatment for sulfasalazine-induced agranulocytosis.
    Chan K; Farooq R
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26178004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
    Alvir JM; Lieberman JA; Safferman AZ; Schwimmer JL; Schaaf JA
    N Engl J Med; 1993 Jul; 329(3):162-7. PubMed ID: 8515788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine and agranulocytosis: re-assessing the risks.
    Drew L
    Australas Psychiatry; 2013 Aug; 21(4):335-7. PubMed ID: 23804114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
    Ransford RA; Langman MJ
    Gut; 2002 Oct; 51(4):536-9. PubMed ID: 12235076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sulphasalazine associated pancytopenia may be caused by acute folate deficiency.
    Logan EC; Williamson LM; Ryrie DR
    Gut; 1986 Jul; 27(7):868-72. PubMed ID: 2874103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spironolactone-induced agranulocytosis.
    Whitling AM; Pérgola PE; Sang JL; Talbert RL
    Ann Pharmacother; 1997 May; 31(5):582-5. PubMed ID: 9161653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of drug-induced agranulocytosis: the case of calcium dobesilate.
    Zapater P; Horga JF; García A
    Eur J Clin Pharmacol; 2003 Mar; 58(11):767-72. PubMed ID: 12634984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group.
    Shapiro S; Issaragrisil S; Kaufman DW; Anderson T; Chansung K; Thamprasit T; Sirijirachai J; Piankijagum A; Porapakkham Y; Vannasaeng S; Leaverton PE; Young NS
    Am J Trop Med Hyg; 1999 Apr; 60(4):573-7. PubMed ID: 10348230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agranulocytosis associated with calcium dobesilate clinical course and risk estimation with the case-control and the case-population approaches.
    Ibáñez L; Ballarín E; Vidal X; Laporte JR
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):763-7. PubMed ID: 11214789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Agranulocytosis in rheumatoid polyarthritis treated with sulfasalazine].
    Pointud P; Cauhape P; Favreau A
    Rev Rhum Mal Osteoartic; 1989 Jun; 56(7):573. PubMed ID: 2569228
    [No Abstract]   [Full Text] [Related]  

  • 40. Systematic review: agranulocytosis induced by nonchemotherapy drugs.
    Andersohn F; Konzen C; Garbe E
    Ann Intern Med; 2007 May; 146(9):657-65. PubMed ID: 17470834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.